Real-world patterns and predictors of first-line maintenance use among patients with newly diagnosed advanced ovarian cancer: Is there an opportunity for change?

被引：0
|
作者：
Liu, Jinan
Thaker, Premal H.
Sah, Janvi
Maiese, Eric M.
Bee, Oscar
Hurteau, Jean
Chan, John
机构：
[1] GlaxoSmithKline, Navy Yard, PA USA
[2] Washington Univ, Sch Med, St Louis, MO USA
[3] STATinMED, Ann Arbor, MI USA
[4] GlaxoSmithKline, Waltham, MA USA
[5] Sutter Hlth, Div Gynecol Oncol, San Francisco, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e18710
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18710
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Real-world Use of Radiation for Newly Diagnosed Brain Metastases in Patients With ALK-positive Lung Cancer Receiving First-line ALK Inhibitor
    Kumar, Sameera
    Wang, Xiaoliang
    Pittell, Harlan
    Calip, Gregory S.
    Weiss, Stephanie E.
    Meyer, Joshua E.
    Royce, Trevor J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (04): : 627 - 634
  • [32] Real-world bevacizumab utilization and outcomes in first-line ovarian cancer.
    Monberg, Matthew J.
    Hall, Jennifer P.
    Moon, Rebecca
    Higson, Olivia
    McLaurin, Kimmie
    Dalvi, Tapashi
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [33] Real-world treatment patterns in recurrent or advanced endometrial cancer patients on first-line systemic therapy in the United States
    Ogando, Yoscar M.
    Chen, Lei
    Zhang, Jingchuan
    Kelkar, Sneha S.
    Prabhu, Vimalanand S.
    Miles, Nicola
    Green, Angela
    Makker, Vicky
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 233 - 234
  • [34] Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
    Moore, K.
    Colombo, N.
    Scambia, G.
    Kim, B. -G.
    Oaknin, A.
    Friedlander, M.
    Lisyanskaya, A.
    Floquet, A.
    Leary, A.
    Sonke, G. S.
    Gourley, C.
    Banerjee, S.
    Oza, A.
    Gonzalez-Martin, A.
    Aghajanian, C.
    Bradley, W.
    Mathews, C.
    Liu, J.
    Lowe, E. S.
    Bloomfield, R.
    DiSilvestro, P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (26): : 2495 - 2505
  • [35] First evidence of olaparib maintenance therapy in patients with newly diagnosed BRCA wild-type ovarian cancer: A real-world multicenter study
    Li, J.
    Youguo, C.
    Mian, H.
    Chen, X.
    Wen, H.
    Kang, Y.
    Liu, K. J.
    Lou, G.
    Wang, X.
    Wen, Q. L.
    Wang, L.
    Lin, Z.
    ANNALS OF ONCOLOGY, 2023, 34 : S1594 - S1595
  • [36] REAL-WORLD TREATMENT PATTERNS AMONG NEWLY DIAGNOSED PATIENTS WITH EROSIVE ESOPHAGITIS IN THE US
    Patel, Dhyanesh A.
    Shaheen, Nicholas J.
    Bui, Bonnie
    Gopal, Murali
    Jacob, Rinu
    Chastek, Benjamin
    Landis, Christina
    Shah, Eric D.
    GASTROENTEROLOGY, 2024, 166 (05) : S942 - S943
  • [37] First-line rucaparib maintenance after hyperthermic intraperitoneal chemotherapy with interval debulking surgery for advanced epithelial ovarian cancer: a real-world study
    Palo, Upasana
    Mondal, Debapriya
    Roy, Somnath
    Bhattacharjee, Arnab
    Ghosh, Anik
    Chakraborti, Basumita
    Mishra, Jagannath
    Bhaumik, Jaydip
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_3) : A36 - A36
  • [38] DISEASE PROGRESSION IN PATIENTS WITH OVARIAN CANCER WHO RECEIVED FIRST-LINE MAINTENANCE THERAPY OR ACTIVE SURVEILLANCE, A US REAL-WORLD ANALYSIS
    Chase, D.
    Perhanidis, J. A.
    Gupta, D.
    Kalilani, L.
    Woodward, T.
    Gonzalez-Martin, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A266 - A267
  • [39] First-line treatment patterns among patients with metastatic pancreatic ductal adenocarcinoma in the real-world setting
    Dennen, Syvart
    Harton, Joanna
    Cockrum, Paul
    Kim, George P.
    MacEwan, Joanna P.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [40] Use of PARPi among patients with advanced ovarian cancer: Results from a real-world database
    Dawood, S.
    Brzozowski, K.
    ANNALS OF ONCOLOGY, 2021, 32 : S740 - S741
12345